Skip to main content
OpenTrials

Clinical trial condition

Resectable Intrahepatic Cholangiocarcinoma

Explore clinical trials studying Resectable Intrahepatic Cholangiocarcinoma. Study availability and eligibility vary by location and protocol.

3 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Resectable Intrahepatic Cholangiocarcinoma trial results

Recruiting

Testing the Combination of the Anticancer Drug Durvalumab With Chemotherapy (Gemcitabine and Cisplatin) at Improving Outcomes for High-Risk Resectable Liver Cancer Before Surgery

NCT06050252

Conditions
Resectable Intrahepatic Cholangiocarcinoma
Locations
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
  • UCHealth University of Colorado Hospital Aurora, Colorado, United States
View all 58 locations
View Trial Details
Recruiting

Selective Internal Radiation Therapy and Capecitabine (Chemotherapy) Treatment for Liver Cancer

NCT05265208

Conditions
Resectable Intrahepatic Cholangiocarcinoma
Locations
  • Centre de Lutte contre le Cancer Eugène Marquis Rennes, Brittany Region, France
  • Groupe SUD-Haut-Lévêque - Centre Hospitalier Universitaire de Bordeaux Pessac, New Aquitaine, France
  • Centre Hospitalier Universitaire de Montpellier Montpellier, France
  • Centre Hospitalier Universitaire de Poitiers Poitiers, France
View Trial Details